GLOBAL NEUROETHICS SUMMIT 2018

OCTOBER 11th - 14th, 2018 / SEOUL, KOREA

2018 GLOBAL NEUROETHICS SUMMIT

OCTOBER 11th - 14th, 2018 CONRAD SEOUL HOTEL / SEOUL, SOUTH KOREA WWW.GLOBALNEUROETHICSSUMMIT.COM NeQN Q1. What is the “ potential impact of a biological model or neuroscientific account of disease on individuals, communities, and society? ” V

TABLE OF CONTENTS

PURPOSE 5 AGENDA 7 OUTLINE 9 EXCURSION DETAILS 15 PEOPLE 17 ORGANIZING COMMITTEE 18 CONSULTANTS 19 MANAGERS 21 DELEGATES 22 HELPFUL INFORMATION 35 NeQN Q2. What are “the ethical standards of biological material and data collection; how do local standards compare to those of global collaborators?” PURPOSE

In a world that is increasingly global – and increasingly engaged in neurosciences – how we educate scientists about the underlying values and ethics that drive brain research across cultural and continental divides is critical. The consequences of cultural misunderstandings are far from trivial for the scientific enterprise. Gaps in understanding lead to missed opportunities for collaboration to advance discoveries; limit our ability to broadly share results and reap the benefits of scientific findings; and result in a failure to recognize the unforeseen short- and long-term risks of research. Neuroethics has emerged as an essential tool for neuroscience serving in a horizon-scanning function to anticipate and address ethical roadblocks ahead and, ultimately, to advance and accelerate neuroscience.

The goal of the 2017 Global Neuroethics Summit was to create a list of neuroethics questions that should be addressed by each brain project. A unique feature of that important list was that, while the questions themselves could be adopted universally, they could also be adapted and informed by the cultural values and frameworks of each country. This was successfully completed and is now in-press as a Perspective article for Neuron. This series continues by taking a different, yet important culturally informed strategy for addressing the societal and ethical implications of emerging neuroscience and neurotechnologies. As neuroscience is now a global endeavor, neuroethics must be equally prepared to address global values.

This 2018 year meeting is a workshop of the Neuroethics Workgroup of the International Brain Initiative (IBI). With this year’s support, we build upon the critical foundation for the fields of neuroscience and neuroethics laid in our first meeting, with the potential for our discussions to inform policy and shape funding priorities for many agencies in the future. This 2018 meeting aligns with the recently formalized efforts of the IBI which, in collaboration with The Kavli Foundation and other key stakeholders from existing and emerging brain projects, recognized neuroethics as one of its top priorities. With this meeting, partners in the IBI as well as representatives from all existing and emerging large-scale national-level brain projects will come together to discuss imperatives for neuroscience as seen through the lens and methods of neuroethics.

The meeting is meant to serve as an idea-incubator for scholarship, research, and curriculum development, as well as for community building for neuroethics in the IBI. The meeting is a also workshop for a special journal issue that Neuron has commissioned as a series of Neuroview papers. Each of the brain projects will provide, prior to the meeting, a draft of a manuscript that discusses why and how they will integrate and implement neuroethics into their brain projects with particular recognition of the five questions from our first paper in Neuron.

Goals and Deliverables • Facilitate a community of multidisciplinary scholars who are attuned to and inclusive of cross-cultural perspectives when engaging in neuroscience and neuroethics research and policy. • Serve as an idea-incubator for research collaborations and future implementation for the IBI and beyond. • Generate a series of high-profile and high-impact publications that establish neuroethics priorities for research and scholarship in global neuroscience projects.

5 NeQN Q3. What is the “moral significance of neural systems that are under development in neuroscience research laboratories? ” AGENDA

7

OUTLINE

THURSDAY, OCTOBER 11 19:00 - 21:00 WELCOME DINNER AND RECEPTION FRIDAY, OCTOBER 12 8:30 - 9:30 WELCOME 9:30 - 10:45 INTRODUCTION OF GLOBAL BRAIN PROJECTS 10:45 - 11:00 OVERVIEW OF 2017 SUMMIT THEMES AND QUESTIONS 11:00 - 11:30 BREAK (END OF OPEN SESSION) 11:30 - 12:30 LUNCH 12:30 - 13:15 IDEA INCUBATOR SESSION 1: PUBLIC-PRIVATE PARTNERSHIPS 13:15 - 13:30 BREAK 13:30 - 14:30 IDEA INCUBATOR SESSION 2: ADVOCACY AND SUSTAINABILITY 14:30 - 16:00 BREAKOUT GROUP DISCUSSION ON COLLABORATION 16:00 - 17:00 BREAK AND RECEPTION 17:00 - 19:00 DINNER AND PRESENTATIONS FROM BREAKOUT GROUPS SATURDAY, OCTOBER 13 8:30 - 8:45 WELCOME 8:45 - 9:00 INTRODUCTION TO GLOBAL BRAIN PROJECT PAPERS 9:00 - 9:30 KOREA BRAIN PROJECT 9:30 - 10:00 AUSTRALIAN BRAIN PROJECT 10:00 - 10:20 BREAK 10:20 - 10:50 CANADIAN BRAIN RESEARCH STRATEGY 10:50 - 11:20 BRAIN PROJECT 11:20 - 11:50 HUMAN BRAIN PROJECT 11:50 - 12:40 LUNCH 12:40 - 13:10 JAPAN BRAIN/MINDS 13:10 - 13:40 US BRAIN INITIATIVE 13:40 - 14:00 BREAK 14:00 - 15:00 BREAKOUT GROUP DISCUSSION ON 2018 SUMMIT THEMES 15:00 - 15:30 BREAK 15:30 - 16:30 PRESENTATIONS FROM BREAKOUT GROUPS 16:30 - 16:45 CONCLUDING REMARKS AND NEXT STEPS 16:45 - 19:00 FAREWELL DINNER SUNDAY, OCTOBER 14 8:30 - 9:30 BREAKFAST RECAP FOR GNS ORGANIZERS AND LEAD AUTHORS 9:35 - 14:00 CULTURAL EXCURSION (OPTIONAL)

9 THURSDAY, OCTOBER 11 ARRIVAL and WELCOME DINNER

CONRAD SEOUL HOTEL 10 Gukjegeumyung-ro (Yeouido) Yeongdeungpo-gu Seoul 07326, Korea Telephone: +82-2-6137-7000 Email: [email protected]

16:00 CHECK-IN AT THE CONRAD SEOUL HOTEL

19:00 - 21:00 WELCOME DINNER/RECEPTION (CONRAD HOTEL 6th FLOOR, STUDIO 4) Welcome and Goals from conference co-chairs Karen Rommelfanger (Emory University Center for Ethics) Sung-Jin Jeong (Korea Brain Research Institute) Remarks from the International Brain Initiative (IBI) Jim Deshler (National Science Foundation) Caroline Montojo (Kavli Foundation)

** BREAKFAST FOR THE FOLLOWING MORNINGS WILL BE AVAILABLE FROM 6:30 AT ZEST, LOCATED ON THE 2ND FLOOR **

10 FRIDAY, OCTOBER 12 OPEN SESSION CONRAD HOTEL 6th FLOOR, STUDIOS 1-3

8:30 - 9:30 WELCOME AND INTRODUCTIONS Co-chairs: Sung-Jin Jeong (Korea Brain Research Institute), Karen Rommelfanger (Emory University Center for Ethics) Partners: Ministry of Science & ICT, National Assembly International Brain Initiative (IBI): Jim Deshler (National Science Foundation), Caroline Montojo (Kavli Foundation) Individual Introductions 9:30 - 10:45 INTRODUCTION AND PRESENTATION OF GLOBAL BRAIN PROJECTS Korea Brain Initiative: Sung-Jin Jeong (Korea Brain Research Institute) Australian Brain Initiative: Linda Richards (University of Queensland) Brain Research Strategy: Judy Illes (University of British Columbia) China Brain Project: Jialin Zheng (Tongji University) EU Human Brain Project: Jan Bjaalie (University of Oslo) Japan Brain/MINDS: Shigeo Okabe (University of Tokyo) US BRAIN Initiative: Walter Koroshetz (National Institutes of Neurological Disorders and Stroke) 10:45 - 11:00 PRESENTATION OF 5 GUIDING QUESTIONS FROM 2017 Karen Rommelfanger (Emory University Center for Ethics) 11:00 - 11:30 BREAK

-END OF OPEN SESSION-

11 FRIDAY, OCTOBER 12 CLOSED SESSION CONRAD HOTEL 6th FLOOR, STUDIOS 1-3

11:30 - 12:30 LUNCH AND INTRODUCTION OF AFTERNOON SESSION (CONRAD HOTEL 6th FLOOR, STUDIOS 8-9) 12:30 - 14:30 IDEA INCUBATOR SESSION 12:30 - 13:15 SESSION 1: PUBLIC-PRIVATE PARTNERSHIPS Data sharing and Ethics (market concerns) - Alvaro Fernandez (SharpBrains) Private sector consumables and neuroethics - Ana Maiques (Neuroelectrics) Policy and public-private transnational regulation - Hermann Garden (Organisation for Economic Cooperation and Development) 13:15 - 13:30 BREAK 13:30 - 14:30 SESSION 2: ADVOCACY AND SUSTAINABILITY Public engagement models (public understanding of science) -Genya Dana (World Economic Forum) Data sharing and Ethics (tech creator concerns) - Matt Bosworth (Emotiv) Hype/communication - Amy Adams (National Institutes of Neurological Disorders and Stroke) Sustainability of neuroethics (Capacity building) - Caroline Montojo (Kavli Foundation) 14:30 - 15:00 DISCUSSION AND INTRODUCTION OF BREAKOUT GROUPS 15:00 - 16:00 BREAKOUT GROUPS I: IDEAS FOR COLLABORATION Education/Training Research/Scholarship Public Outreach Public-Private/Cross-sectorial collaboration 16:00 - 17:00 BREAK AND RECEPTION 17:00 - 19:00 DINNER (CONRAD HOTEL 6th FLOOR, STUDIOS 8-9) 17:00 - 18:00 PRESENTATIONS FROM BREAKOUT GROUPS 18:00 - 18:15 CLOSING

12 SATURDAY, OCTOBER 13 MEETING DAY and FAREWELL DINNER CONRAD HOTEL 6th FLOOR, STUDIOS 1-3

8:30 - 8:45 WELCOME Sung-Jin Jeong (Korea Brain Research Institute), Karen Rommelfanger (Emory University Center for Ethics) 8:45 - 11:40 PAPER PRESENTATIONS AND DISCUSSIONS 8:45 - 9:00 Introduction: Mariela Zirlinger (Neuron) 9:00 - 9:30 Korea Brain Project: Inyoung Lee (Hongik University) 9:30 - 10:00 Australian Brain Alliance: Adrian Carter (Monash University) 10:00 - 10:20 BREAK 10:20 - 10:50 Canadian Brain Research Strategy: Judy Illes (University of British Columbia) 10:50 - 11:20 China Brain Project: Guoyu Wang (Fudan University) 11:20 - 11:50 Human Brain Project: Arleen Salles (Uppsala University) 11:50 - 12:40 LUNCH (CONRAD HOTEL 6th FLOOR, STUDIOS 8-9) 12:40 - 13:40 PAPER PRESENTATIONS AND DISCUSSIONS (CONTINUED) 12:40 - 13:10 Japan Brain/MINDS: Norihiro Sadato (National Institute for Physiological Sciences) 13:10 - 13:40 US BRAIN Initiative: Khara Ramos (National Institutes of Neurological Disorders and Stroke) 13:40 - 14:00 BREAK 14:00 - 15:00 BREAKOUT GROUPS II: ORGANIZATION OF THEMES Education/Training Research/Scholarship Public Outreach Public-Private/Cross-sectorial collaboration 15:00 - 15:30 BREAK 15:30 - 16:30 PRESENTATIONS FROM BREAKOUT GROUPS 16:30 - 16:45 CONCLUDING REMARKS AND NEXT STEPS Karen Rommelfanger (Emory University Center for Ethics), Sung-Jin Jeong (Korea Brain Research Institute) 16:50 - 17:10 SHUTTLE TO RESTAURANT 17:20 - 19:00 FAREWELL DINNER Baek Ni Hyang Chinese Restaurant

13 SUNDAY, OCTOBER 14 CHECK-OUT CULTURAL EXCURSION

** CHECK-OUT IS BY 11:00 **

8:30 - 9:30 BREAKFAST RECAP (ONLY LEAD AUTHORS AND GNS ORGANIZERS) Located at Zest, 2nd floor 9:45 - 14:00 AFTERNOON EXCURSION MEET IN LOBBY AT 9:35 Myeongdong Myeongdong Cathedral Namsan Seoul Tower

THANK YOU FOR JOINING US AT THE 2018 GLOBAL NEUROETHICS SUMMIT! YOUR PARTICIPATION IS IMPERATIVE FOR THE ADVANCEMENT OF NEUROETHICS COLLABORATION AND RESEARCH, AND WE ARE GRATEFUL THAT YOU WERE ABLE TO WORK WITH US THIS YEAR. WE HOPE YOU ENJOYED YOUR TIME IN SEOUL. WE LOOK FORWARD TO WORKING WITH YOU AGAIN SOON!

14 CULTURAL EXCURSION

MYEONGDONG Located in the heart of Seoul, Myeongdong is Seoul’s shopping mecca and is a must-see for tourists. However, it is not just a shopping destination. Myeong- dong is also a hub of commerce, banking and culture with a daytime population of 1.5-2 million. For shoppers there is a mixture of street stalls and retail outlets selling everything from high fashion to casual attire, as well as many Korean cosmetics stores offering high-quality products at competitive prices.

MYEONGDONG CATHEDRAL Myeongdong Cathedral, the first Western-style brick building in Korea, was completed in May 1898. It is located in the shopping district of Myeongdong. Myeongdong Cathedral played an important role as a center of political and labor protests in the 1970s and 1980s and became the mecca of pro-democracy activities.

This portion inlcudes a meeting with Jeong Jae-woo, the president of Nicholas Cardinal Cheong Graduate School for Life at the Catholic University of Korea.

LUNCH AT HANCOOK (한쿡) HanCook is an elegant Korean restaurant located in Namsan Seoul Tower serving the traditional beauty and tastes of Korea in a comfortable setting.

NAMSAN SEOUL TOWER Namsan Seoul Tower was the first tower-type tourism spot in Korea.

The top of the tower is at almost 480m above sea level, including Namsan Mountain (243m) and the tower’s own height (236.7m), making it one of the tallest towers in the Orient. You will see the beautiful scenery at the observatory as well as the outside of the tower in this representative landmark of Seoul.

15 NeQN Q4. How could “ brain interventions impact or reduce autonomy? ” PEOPLE

17 ORGANIZING COMMITTEE

SUNG-JIN JEONG Sung-Jin Jeong is a principal Researcher at the Korea Brain Research Institute. She received her Ph.D. in Molecular Biology from Seoul National University, and then worked as a Research Fellow at General Hospital for seven years. She then worked as a Research Fellow and Staff Scientist at Children’s Hospital Boston, before joining the Korea Brain Research Institute in 2013. Dr. Jeong recently published an article in Neuron, describing the history and goals of the Korean Brain Initiative. This initiative is centered on deciphering the brain functions and mechanisms that underlie decision-making, and the major goal is to map a functional connectome of the brain. The project also encourages the development of novel techniques and technologies, and should ultimately have socioeconomic ramifications that facilitate global collaboration across the world. KHARA RAMOS Dr. Khara Ramos is a Senior Science Policy Analyst in the Office of Scientific Liaison within the Office of the Director of the National Institute of Neurological Disorders and Stroke, a part of the National Institutes of Health. She is leading efforts to integrate neuroethics into the NIH BRAIN Initiative. A neuroscientist and former AAAS Science and Technology Policy Fellow, she has broad interest in neuroscience research, with specific focus on how advances in neuroscience intersect with society.

KAREN ROMMELFANGER Dr. Karen S. Rommelfanger received her PhD in neuroscience and postdoctoral training in neuroscience and neuroethics. Her research explores how evolving neuroscience and neurotechnologies challenge societal definitions of disease and medicine. Dr. Rommelfanger is an Assistant Professor in the Departments of Neurology and Psychiatry and Behavioral Sciences, the Neuroethics Program Director at Emory University’s Center for Ethics, and Senior Associate Editor at the American Journal of Bioethics Neuroscience. In recognition of her leadership in the neuroethics community, Dr. Rommelfanger was appointed to the NIH BRAIN Initiative’s Neuroethics Division and acts as the Division ambassador to the Human Brain Project Ethics Advisory Board. She is dedicated to cross-cultural work in neuroethics and also serves as ethicist to the China- Mental Health Alliance. A key part of her work is fostering communication across multiple stakeholders in neuroscience. As such she edits the largest international online neuroethics discussion forum The Neuroethics Blog and she is a frequent contributor and commentator in popular media such as The Times, USA Today and The Huffington Post. NORIHIRO SADATO Dr. Sadato is a professor of National Institute for Physiological Sciences in Japan since 1999. After trained as a diagnostic radiologist, he entered into the functional neuroimaging field in 1990. Dr. Sada- to is interested in understanding the mechanisms of plastic change in the human brain accompanied by learning, sensory deprivation, and development explored by functional MRI. Recently he focuses on the development of the social cognition and its neural correlates. Dr. Sadato has been the chair of the Ethics Committee of The Japan Neuroscience Society since 2008.

ARLEEN SALLES Arleen Salles is the Director of the Neuroethics Program at CIF (Centro de Investigaciones Filosoficas) in Buenos Aires, Argentina and a Senior Researcher in the Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden. She is also a task leader and research collaborator in the Ethics and Society subproject (SP12) of the EU-flagship Human Brain Project. Salles received her M.A and Ph.D in philosophy from SUNY Buffalo, USA. Her research interests include the impact of neuroscientific research on human and personal identity, ethical issues raised by simulation and consciousness, the nature and methodology of neuroethics, and the impact of cultural context on the development of the field.

18 CONSULTANTS

ADRIAN CARTER Dr. Adrian Carter is an NHMRC Career Development and Senior Research Fellow and Head, Neuroethics and Public Policy Group at the School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University. He is also Director, Neuroethics Program, Australian Research Council Centre of Excellence for Integrative Brain Function and Chair, Australian Brain Alliance Neuroethics Subcommittee, Australian Academy of Science. His research examines the impact of neuroscience on our understanding and treatment of addiction and other compulsive behaviours, including: agency, identity, moral responsibility, the use of coercion and the capacity for voluntary control of addictive or compulsive behaviours; and the use of emerging technologies such as brain stimulation and neuroimaging, to treat addiction. He received the Australasian Professional Society of Alcohol and Other Drugs “Early Career Award for Excellence in Research and Science” (2012) and the Australian National Drug and Alcohol Award for Excellence in Research (2010). He has over 120 publications, including the book ‘Addiction Neuroethics: The Promises and Perils of Addiction Neuroscience’ (Cambridge University Press, 2012). Dr Carter has been an advisor to the World Health Organization, the European Monitoring Centre for Drugs and Drug Addiction, the Australian Ministerial Council on Drugs Strategy and United Nations Office on Drugs and Crime. He is also Deputy Chair of the Australian Academy of Science Early and Mid Career Research Forum Executive.

ARISA EMA Arisa Ema is the Assistant Professor at the University of Tokyo and Visiting Researcher at RIKEN Center for Advanced Intelligence Project in Japan. She is a researcher in Science and Technology Studies (STS), and her primary interest is to investigate the benefits and risks of artificial intelligence by organizing an interdisciplinary research group. She is a co-founder of the Acceptable Intelligence with Responsibility Study Group (AIR), established in 2014, which seeks to address emerging issues and relationships between artificial intelligence and society. She is a member of the Ethics Committee of the Japanese Society for Artificial Intelligence (JSAI), which released the Japanese Society for Artificial Intelligence Society Ethical Guidelines in 2017. She is also one of the organizers of the 2017 “IEEE Ethically Aligned Design, Version 1 Workshop in Japan.” She obtained her Ph.D. from the University of Tokyo in 2012 and previously held a position as Assistant Professor at the Hakubi Center for Advanced Research, Kyoto University.

TAMAMI FUKUSHI Tamami Fukushi is the Deputy Manager in the Department of Research Infrastructure at Japan’s Agency for Medical Research and Development (AMED). She is also the consultant for the Global Neuroethics Summit. She started her career in Neuroethics in 2005 at the Research Institute of Science and Technology for Society (RISTEX), Japan Science and Technology Agency (JST) after 10 years of research in neural control of movement. Her current interest is ELSI of advanced technology of neuroscience in the context of science policy and regulatory science. She recently published a book titled “Social Implementation of Neurodegenerative Disease Research and Neuroethics” In: Wada, K., (ed.) Neurodegenerative Disorders as Systemic Diseases. Pp.295-304, Springer and “Neuroethics in Japan” In: Rommelfanger, K., (ed.) Handbooks in Neuroethics. Routledge.

19 CONSULTANTS

JUDY ILLES Dr. Illes is the Professor of Neurology and Canada Research Chair in Neuroethics at the University of British Columbia. She is the Director of the National Core for Neuroethics at UBC, and faculty in the Centre for Brain Health at UBC and at the Vancouver Coastal Health Research Institute. Dr. Illes’ research focuses on ethical, legal, social and policy challenges specifically at the intersection of the sciences of the central nervous system and biomedical ethics. This includes empirical studies in stem cells and regenerative medicine, neurogenetics, brain injury, aging and neurodevelopmental disorders, mental health and addictions, and the commercialization of neuroscience and personalization of health. Her research results in actionable practical guidance, frameworks for empowering the ethical development and communication of science, and evidence for informed policy-making. She also leads a robust program of research and outreach devoted to improving public literacy about brain research and engaging stakeholders on a global scale. Dr. Illes founded, with others, the International Neuroethics Society in 2006. She is the Vice Chair of the Standing Committee on Ethics for the Canadian Institutes of Health Research. She is a member of the Dana Alliance for Brain Initiatives and a Canadian representative to IBRO US-Canada Committee. Dr. Illes was elected to the Royal Society (Life Sciences) in 2012), to the Canadian Academy of Health Sciences in 2011, and to the American Association for the Advancement of Science (Neuroscience) in 2013. Her latest book (Oxford University Press, 2017) is Neuroethics: Anticipating the Future. CAROLINE MONTOJO Caroline Montojo is a Science Program Officer at The Kavli Foundation, where she has been involved in efforts to advance basic science, including a global movement to create an International Brain Initiative. Prior to joining the Foundation, Dr. Montojo served as a postdoctoral research fellow in the Semel Institute for Neuroscience and Human Behavior at the University of , Los Angeles (UCLA). Her research at UCLA focused on investigating neural biomarkers for psychiatric illness using functional magnetic resonance imaging techniques, for which she was awarded the Arnold Scheibel Distinguished Postdoctoral Fellow in Neuroscience Award and the Stephen R. Mallory Schizophrenia Research Award. Dr. Montojo received her B.A. from the University of California, Berkeley, and completed her M.A. and Ph.D. at Johns Hopkins University.

ILINA SINGH Ilina Singh is Professor of Neuroscience & Society at the University of Oxford, where she holds a joint appointment between the Department of Psychiatry and the Faculty of Philosophy (Oxford Centre for Neuroethics and Oxford Uehiro Centre for Practical Ethics). Her work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families. Recent projects include the ADHD VOICES project (www.adhdvoices.com); Neuroenhancement Responsible Research and Innovation (www.nerri.eu); and the Urban Brain Project (www.urbanbrainlab. com). Professor Singh has published widely in eminent journals, including Nature, Nature Reviews Neuroscience, Social Science and Medicine, and the American Journal of Bioethics. She is the lead editor of a new volume: BioPrediction, Biomarkers and Bad Behavior: Scientific, Ethical and Legal Challenges (co- edited with Walter-Sinnott Armstrong and Julian Savulescu), published by Oxford University Press. She has acted as an advisor to the Nuffield Council on Bioethics, NICE, NIMH and other organisations. She is co-editor of the journal BioSocieties and on the editorial board of the American Journal of Bioethics-Neuroscience and Qualitative Psychology. JIALIN ZHENG Jialin Zheng is Dean of the Tongji University School of Medicine, where he is a Professor of Neuroscience and Regenerative Medicine. He is simultaneously a Professor of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center (UNMC). Dr. Zheng’s research focuses on the understanding and treatment of neurodegenerative disorders such as Parkinson’s Disease. Ultimately it is the mission of his lab to develop drugs that will inhibit neurotoxin production and enhance neuronal repair in the brain. Dr. Zheng has been at the fore of UNMC’s collaborative efforts in China. He is the Director of UNMC’s Asia Pacific Rim Development Program and has worked to create more than 10 partnerships in China, including the formation of the first joint U.S./Chinese M.D./Ph.D. program. Dr. Zheng received his M.D. from Xuzhou Medical College in China and served as a visiting scholar at the State University of New York at Buffalo prior to joining UNMC.

20 MANAGERS

EMILY FLOYD Emily Floyd is the manager for the Global Neuroethics Summit, as well as the Emory Integrity Project at the Emory University Center for Ethics. Emily primarily focuses on program development and implementation. Emily received her undergraduate degree from Saint Louis University in Political Science, her graduate degree from University of South Florida in Higher Education, and will be completing her Master of Religious Leadership degree at the Candler School of Theology at Emory University in May 2019. Emily works to create and implement environments and events that engage participants, promote community, and have lasting intellectual impact.

CELESTE FONG Celeste Fong is the assistant manager for the Global Neuroethics Summit. She is currently pursuing a master’s degree in Bioethics with a certificate in Neuroethics at Emory University. Her primary interests include the relationships between the neurobiology of mental disorders and moral value in decision-making. Previously, Celeste completed undergraduate degrees in Neuroscience and Philosophy at the University of at Birmingham. She is very much looking forward to meeting everyone and participating in the 2018 GNS in Seoul, S. Korea this Fall.

HYUNJUNG KIM Hyunjung is the assistant manager for the Global Neuroethics Summit and works at the Brain Research Policy Center of the Korea Brain Research Institute(KBRI). She completed her master’s certificate program in political science at the Graduate School of Sogang University; International Relations is her specialty. Prior to joining the KBRI in 2016, she has worked in the Department of Climate Change Action at the Korea Environment Corporation(Keco) and participated in 2014 United Nations Climate Change Conference COP20 as a government delegate.

HEON SEOK Heon is a Senior Researcher at the Korea Brain Research Institute in Daegu, Korea. There, he works in project planning, responsible for the analysis of domestic and overseas brain research trends. He com- pleted his Ph.D. in the Department of Biomedical Science at the University of Sheffield in the UK. He was also a research associate at the School of Nano-bioscience Chemical Engineering at Ulsan National Institute of Science and Technology, as well as an assistant professor in the Department of Biomedical Sciences at Jungwon University. Heon’s primary research interest is in the molecular mechanisms of synaptic plasticity and memory, for which he has several publications.

STEPHENI UH Stepheni Uh graduated from Emory University with degrees in Neuroscience and Ethics. As the 2014- 15 Bobby Jones Fellow, she completed her MPhil in Behavioural and Neural Sciences at the University of St Andrews, Scotland. She has since engaged in exploratory and clinical research at the University of ’s Center for Neuroscience & Society and the Center for Autism Research at the CHOP. Since her time at Emory, she has also collaborated with the Dalai Lama and Emory’s Emory-Tibet Science Initiative, providing unique cross-cultural perspectives into her studies. Her primary interests lie in the ethical, social, and legal implications of human neuroscience research as well as the translation of science for policy across diverse populations. Stepheni was recently awarded the Gates Cambridge Scholarship to pursue her PhD at the University of Cambridge’s MRC Cognition and Brain Sciences Unit. She will investigate the neurophysiological foundations of resilience in children growing up in poverty with the hope to better inform interventions and policies targeting human development and well-being.

21 DELEGATES

AMY ADAMS Dr. Amy B. Adams currently serves as Director of the Office of Scientific Liaison (OSL) at the National Institute of Neurological Disorders and Stroke at NIH, where she leads OSL efforts to provide a seamless flow of information on research advances and initiatives to the various stakeholders including scientific and academic communities, as well as policy-makers, patients, and the public. OSL manages the NINDS website, an important tool in broadly conveying this information. Previously, she served as the Director of the National Institute of Dental and Craniofacial Research (NIDCR) Office of Science Policy and Analysis (OSPA) since 2008, where she was responsible for coordinating scientific planning efforts, policy analysis, and providing evaluating and reporting services for the NIDCR. Prior to joining NIDCR, Dr. Adams served as an American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellow in the Office of the (NIH) Director, and subsequently served as Special Assistant to the NIH Director. Dr. Adams earned her Ph.D. in cell biology from the Yale University School of Medicine, where her research focused on the genetic and cellular basis for neurotransmitter control of behavior in C. elegans. She received her B.S. in biology from the Massachusetts Institute of Technology.

TASIA ASAKAWA Tasia Asakawa is currently the Director of Development and Communication at the International Brain Research Organization (IBRO) in Paris, France. Tasia obtained her MSc degree in History of Science from the University of Oxford in the United Kingdom. Her work includes building global partnerships, collaborations and membership to support neuroscience research, teaching, learning and advocacy around the world; developing, planning and implementing strategic communications, marketing and branding to promote IBRO activities, and brain research, awareness and achievements; and reinforcing and advancing the work of IBRO members, committees and partners within the organization’s mission and objectives.

JAN BJAALIE Jan Bjaalie, M.D., Ph.D., is professor at the Institute of Basic Medical Sciences, University of Oslo, and leader of the Neuroinformatics Platform of the EU Human Brain Project. He was founding Executive Director of the International Neuroinformatics Coordinating Facility (INCF) and is currently head of the INCF Norwegian Node and member of the INCF Council for Training, Science, and Infrastructure. His research group has studied wiring patterns in the brain and developed data systems for organizing and managing heterogeneous neuroscience research data by use of a new generation of digital brain atlases. The group develops software and workflows for analysis of data integrated in the atlases (“Google maps of the brain”). Jan Bjaalie is Chief Editor of Frontiers in Neuroinformatics and Section editor of Brain Structure and Function.

MATTHEW BOSWORTH Matthew Bosworth is Director of Cloud and Data Engineering and the Data Protection Officer at EMOTIV, the global leader in contextualized neuroinformatics. At EMOTIV he is responsible for the privacy, security, and availability of one of the world’s largest databases of EEG data. Previously, Mr. Bosworth was Principal Research Software Engineer and a member of the HIPAA Technical Working Group at NeuroPace, where he was responsible for the world’s largest database of ambulatory ECoG recordings. His professional experience includes engineering, management, and entrepreneurship. He has participated in both GDPR and HIPAA implementations. Additionally he has significant experience in firmware development, database architecture, web engineering, and cross-cultural engineering management. He earned his MS in computer engineering at the Institute for Complex Engineered Systems at Carnegie Mellon University, and his BS in computer engineering at Tulane University. In his spare time he enjoys international travel, bicycle touring, and yoga.

22 DELEGATES

JAMES BOURNE James Bourne is an Associate Professor in the Australian Regenerative Medicine Institute at Monash University. He completed his undergraduate training in Biochemistry (Hons) at the Imperial College of Science, Technology and Medicine, London and PhD in the field of Neuropharmacology with the Ministry of Defence and King’s College, London. He then relocated to to undertake a Postdoctoral position at the Vision, Touch and Hearing Research Centre at UQ, later moving to Monash University where in 2007 he started up his own research group. James holds an NHMRC Senior Research Fellowship, is a member of the NHMRC Research Committee and has a strong track record in the field of neural development and regeneration of the visual system. He heads the Bourne group, with his skills and expertise in nonhuman primate research enabling the group to undertake cross-disciplinary research collaborations which form an important component of translational research to humans.

JENNIFER CHANDLER Jennifer A. Chandler researches and writes about the legal and ethical aspects of biomedical science and technology, with focuses on mental health law and policy, neuroethics, organ donation and regenerative medicine. She has published widely in legal, bioethical and health sciences journals and is the co-editor of the recent book Law and Mind: Mental Health Law and Policy in Canada (2016). She is an elected member of the Board of Directors of the International Neuroethics Society, and serves on international editorial boards in the field, including Clinical Neuroethics (part of the Cambridge Quarterly of Healthcare Ethics), the Springer Book Series Advances in Neuroethics, and the Palgrave- MacMillan Book Series Law, Neuroscience and Human Behavior. She holds the Bertram Loeb Research Chair at the University of Ottawa, leading several research teams addressing trust in the organ and tissue donation system, family decision-making at end of life, and the law and ethics of ante-mortem interventions intended to support organ donation. She is also a co-lead of the Research Core on Ethics, Law and Society for the Canadian National Transplant Research Program. At the University of Ottawa, Professor Chandler teaches courses in Mental Health Law and Neuroethics, Medical-Legal Issues, and Tort Law. She holds degrees in Law from Harvard University and Queen’s University, and a degree in Biology from the University of Western Ontario. She joined the University of Ottawa’s Faculty of Law in 2002, after serving as clerk to the Hon. Mr. Justice John Sopinka of the Supreme Court of Canada.

GENYA DANA Genya is the Head of Precision Medicine at the World Economic Forum. She leads the co-design, testing and scaling of pilot projects with governments, industry, civil society, and academia to tackle policy and governance challenges around moving toward a tailored and personalized approach to health and healthcare. She is an internationally recognized expert on the policy and science of synthetic biology and gene editing, and has advised foreign policy makers on the implications of emerging technologies. She served as a U.S. negotiator on science, technology and innovation in multi-lateral organizations like the United Nations, worked to advance science, technology and innovation for sustainable development with a focus on Africa, and developed international partnerships to support scientific research on brain science and biological engineering. She has degrees in biology, public policy, and risk assessment, and conducted her PhD research in South Africa.

23 DELEGATES

JAMES DESHLER James Deshler is the Deputy Director of the Division of Biological Infrastructure at the National Science Foundation (NSF). Dr. Deshler received his bachelor’s degree in Microbiology and Immunology and his Ph.D. in RNA Biology from the University of California, Los Angeles. He did his postdoctoral fellowship at City of Hope, and other post-graduate work at Harvard Medical School. In 1997, he became a faculty member in Biology at Boston University, where he remained for 11 years. Among his many accomplishments, he and his laboratory designed a program called REPFIND, which they used to study localization of messenger RNAs. In his role at the NSF, he works with scientific communities and the Office of Science Technology and Policy to develop strategies of scientific investments, in order to maintain the role of the U.S. as a leader in cutting- edge biological sciences.

JAMES EBERWINE Dr. Eberwine is the Elmer Holmes Bobst Professor of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania where he also serves as Co-Director of the PENN Program in Single Cell Biology. He also is Adjunct Professor of Molecular Medicine at The Scripps Research Institute. Dr. Eberwine developed single cell PCR, the aRNA amplification protocol, TIVA in vivo analysis and coined the phrase “expression profile” to describe the relative abundances of RNAs. Dr. Eberwine’s work has highlighted the kinetics of translation in neuronal dendrites, pioneered the concept of cytoplasmic RNA splicing and illuminated the role of RNA populations in establishing and maintaining cellular phenotype. Dr. Eberwine is an inventor on over 170 patent applications and was elected to the National Academy of Inventors in 2014. Dr. Eberwine has organized several international meetings and symposia under the auspices of a variety of entities including the European Molecular Biology Organization and Cold Spring Harbor Labs. Dr. Eberwine has served as a member of the Board of Scientific Counselors for NIDA, is a member of the external Advisory Board for the Institute of Genome Biology of the University Illinois and is a member of the Scientific Advisory Board for the EP Abraham Trust Fund of Sir William Dunn School of Pathology, Oxford University. Dr. Eberwine is on Council for the National Institute for Alcoholism and Alcohol Abuse and a member of the newly formed Multi Council Working Group at NIH, which consults on the Brain Initiative. Dr. Eberwine originated and directed the Cold Spring Harbor Summer Course formerly entitled “Cloning of Neural Genes” and now called “Advanced Techniques in Neuroscience”. Dr. Eberwine has directed or taught in this course 21 times over its’ 31 year history. In 2012, he developed and Co-Directed the first single cell course at Cold Spring Harbor entitled “Single Cell Techniques”.Dr. Eberwine also co-developed the Neuroscience School of Advanced Study Course on Single Cell Analysis. Dr. Eberwine has given many honorary/plenary talks and received various awards including two NARSAD Distinguished Investigator Awards, a MERIT award from NIH, the NIH Pioneer Award, an Ellison Foundation Senior Scholar Award, the McKnight Technological Innovations in Neuroscience Award and the Brain Research Foundation Science Innovation Award.

MICHELE FARISCO Michele Farisco is part of CRB’s neuroethics research team. He was recently appointed Associate Professor of Moral Philosophy in . He holds a degree in Philosophy from University of Naples “L’Orientale” in 2003, a PhD in “Ethics and Anthropology. History and Foundation” from University of Lecce in 2008 and a Master degree in Biolaw from the University of Rome “Lumsa” in 2009. He spent time on an exchange grant from the European Neuroscience and Society Network within the European Science Foundation joining the Coma Science Group of the University of Liège (Belgium). He is the head of the “Science and society” research unit of Biogem Genetic Research Centre in Ariano Irpino (Italy). He is the author of three books and several articles about posthuman philosophy and philosophical, ethical and legal implications (ELSI) of genetics and neuroscience. Michele Farisco is currently working on his second PhD about the neuroscience of disorders of consciousness (from laboratory to clinics). He will study the ethical and legal issues emerging from neuroscientific investigation of Disorders of Consciousness and related technological applications. The project is a part of the European Union flagship Human Brain Project.

24 DELEGATES

LESLEY FELLOWS Dr. Lesley Fellows is a neurologist specializing in disorders of cognition. She has a particular interest in the functions of the frontal lobes. Her research program focuses on the brain basis of decision making in humans, using the tools of cognitive neuroscience. She studies how focal brain damage or neurochemical dysfunction affects all aspects of decision making, how options are generated and organized, how they are valued and compared, and how choices are made. She is also interested in more general questions about the roles of the frontal lobes in the regulation of emotion, the expression of personality traits, and the representation of past and future information. This work has relevance for understanding impaired executive function following frontal lobe injury from aneurysm rupture, stroke, or tumour growth, as well as in degenerative conditions such as Parkinson’s Disease and some forms of dementia. It also provides insights into how the component processes that underly decision making are carried out in the intact brain.

ALVARO FERNANDEZ Alvaro Fernandez, named a Young Global Leader, runs SharpBrains, an independent market research firm tracking applied neuroscience. A recognized public speaker, he has been quoted by The New York Times, The Wall Street Journal, CNN, Reuters, and Associated Press, among others. Alvaro is the Editor- in-chief of seminal market reports on Pervasive Neurotechnology and Digital Brain Health, and co- author of the book The SharpBrains Guide to Brain Fitness. He enjoys serving in the World Economic Forum’s Council on the Future of Human Enhancement, and in the Global Teacher Prize Academy run by the Varkey Foundation. Alvaro holds an MBA and MA in Education from Stanford University and a BA in Economics from Universidad de Deusto, in his native Spain.

TYR FOTHERGILL Dr. Tyr Fothergill is a Research Fellow in Ethics Support and Researcher Awareness on the Human Brain Project in the Centre for Computing and Social Responsibility, Faculty of Technology at De Montfort University. Tyr originally trained as a palaeopathologist studying signs of disease and injury in skeletal remains from archaeological sites, but her interest in the processes and nature of research and innovation led to a shift in personal research focus. Tyr is interested in data ethics, technology ethics and neuroethics; ethics communication and outreach; responsible data governance; archaeological insights into human-nonhuman relationships in digital environments; neuroscience history; and developing a temporally-contingent framework for researcher reflection within Responsible Research and Innovation. Tyr is also an Auroran (Women in Leadership in HE) with interests in intersectionality, representation, and equality issues.

HERMANN GARDEN My research and health policy interests are the development of innovative therapies and diagnostics for unmet medical needs and cross-sectoral collaboration. I trained in Biology and Pharmacy at the University of Düsseldorf, Germany: PhD in Biology (2003); graduation in Pharmacy (2004). I worked several years as the Deputy Head of the Pharmaceutical Medicines Unit at the Swiss Tropical and Public Health Institute, Basel. My passion for health system strengthening and product development partnerships stems from frequent work assignments in Sub-Saharan Africa. Subsequently I moved to the World Health Organization (WHO) where I coordinated the Better Medicines for Children project and the Paediatric medicines Regulators Network (PmRN). In 2011 I joined Novartis Vaccines and Diagnostics (Siena, Italy) as a Senior Clinical Research Scientist where I led clinical development programmes in pandemic and paediatric vaccines. In my current position as a Health Policy Analyst at the OECD (Science and Technology Policy Division) I support the Working Party on Biotechnology, Nanotechnology and Converging Technologies (BNCT); foci of my work are: the development and use of novel technologies in biomedical research and clinical application; advancing regulatory science; and, ethical, legal and social implications of emerging technologies.

25 DELEGATES

HANK GREELY Henry T. “Hank” Greely is the Deane F. and Kate Edelman Johnson Professor of Law and Professor, by courtesy, of Genetics at Stanford University. He specializes in ethical, legal, and social issues arising from advances in the biosciences, particularly from genetics, neuroscience, and human stem cell research. He chairs the California Advisory Committee on Human Stem Cell Research and the steering committee of the Stanford University Center for Biomedical Ethics, and directs the Stanford Center for Law and the Biosciences and the Stanford Program in Neuroscience and Society. He serves as a member of the NAS Committee on Science, Technology, and Law; the NIGMS Advisory Council, the Institute of Medicine’s Neuroscience Forum, and the NIH Multi-Center Working Group on the BRAIN Initiative. Professor Greely graduated from Stanford in 1974 and from Yale Law School in 1977. He served as a law clerk for Judge John Minor Wisdom on the Court of Appeals for the Fifth Circuit and for Justice Potter Stewart of the United States Supreme Court. He began teaching at Stanford in 1985. MANUEL GUERRERO Manuel Guerrero is a sociologist and bioethicist with extensive experience in human rights. He holds a Postgraduate Diploma in Medical Ethics and Research Ethics, and a PhD in Sociology. He is Assistant Professor in bioethics at the Department of Bioethics and Medical Humanities in the Faculty of Medicine and of ethics at the Center for the Study of Applied Ethics in the Faculty of Philosophy and Humanities at the University of Chile. He currently works as Research Coordinator at the Department of Neurobiology, Care Sciences and Society, in the Division of Neurogeriatrics at the Karolinska Institutet, and is Visiting Researcher in Philosophy of the Brain and Neuroethics at the Centre for Research Ethics and Bioethics, at Uppsala University. He is part of the Human Brain Project (HBP), where he is task leader for the Ethics Rapporteur Programme and collaborates, as a Postdoctoral researcher, with the Neuroethics and Philosophy work team. His research interests combine philosophy, social sciences and neuroethics, with focus on the ethical and social implications of brain research and neurotechnologies.

SYD JOHNSON L. Syd M Johnson, PhD is an Associate Professor of Philosophy & Bioethics in the Departments of Humanities, and Kinesiology & Integrative Physiology at Technological University. She received her PhD in Philosophy at University at Albany, State University of New York. Her current research focuses on ethical and epistemic issues related to brain injuries, with an emphasis on sport- related concussion, disorders of consciousness, and brain death.

BANG-OOK JUN Bang-Ook Jun has been a Professor of Biology at Gangneung-Wonju National University since 1986. He received his Ph.D. in Seoul National University, Department of Botany in 1986. He completed his postdoctoral training at the University of Florida, Department of Botany. He was a Visiting Professor of University of Calgary, Faculty of Communication and Culture and is now a Visiting Professor of American University of Sovereign Nations, Arizona. He was the President of Gangneung-Wonju National University in 2012-2015. He was the President of Korean Bioethics Association in 2008-2009. He has contributed to the Asian Bioethics Association as Vice-President for Korea in 2010-2014 and as President since 2016. He has written articles including “Ethical Issues on the Human Embryonic Genome Editing” and “The Ethics of Therapeutic Gene Editing Research.” His main research focus is on the ethics of emerging biotechnologies.

26 DELEGATES

WALTER KOROSHETZ Walter J. Koroshetz, M.D., was selected Director of NINDS on June 11, 2015. Dr. Koroshetz joined NINDS in 2007 as Deputy Director, and he served as Acting Director from October 2014 through June 2015. As NINDS Director, Dr. Koroshetz directs program planning and budgeting, and oversees the scientific and administrative functions of the Institute. He has held leadership roles in many NIH and NINDS programs including the NIH’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, the NIH Blueprint for Neuroscience Research, the Traumatic Brain Injury Center collaborative effort between the NIH intramural program and the Uniformed Health Services University, and the establishment of the NIH Office of Emergency Care Research. Additionally, Dr. Koroshetz serves as Chair of the Interagency Pain Research Coordinating Committee (IPRCC) and the Executive Committee for the NIH Pain Consortium. Before joining NINDS, Dr. Koroshetz served as Vice Chair of the neurology service and Director of stroke and neurointensive care services at Massachusetts General Hospital (MGH). He was a professor of neurology at Harvard Medical School (HMS) and led neurology resident training at MGH between 1990 and 2007. Over that same period, he co-directed the HMS Neurobiology of Disease course with Drs. Edward Kravitz and Robert H. Brown. A native of Brooklyn, New York, Dr. Koroshetz graduated from Georgetown University and received his medical degree from the University of Chicago. He trained in internal medicine at the University of Chicago and Massachusetts General Hospital. Dr. Koroshetz trained in neurology at MGH, after which he did post-doctoral studies in cellular neurophysiology at MGH with Dr. David Corey, and later at the Harvard neurobiology department with Dr. Edward Furshpan, studying mechanisms of excitoxicity and neuroprotection. He joined the neurology staff, first in the Huntington’s Disease (HD) unit, followed by the stroke and neurointensive care service. A major focus of his clinical research career was to develop measures in patients that reflect the underlying biology of their conditions. With the MGH team he discovered increased brain lactate in HD patients using MR spectroscopy. He helped the team to pioneer the use of diffusion/perfusion-weighted MR imaging and CT angiography/perfusion imaging in acute stroke.

INYOUNG LEE Inyoung Lee is a Professor at Hongik University, College of Law. She received B.A, M.A, and Ph.D. degrees in Criminal Law in 1983, 1986 and 1994 at Yonsei University. She was a member of the Korean National Bioethics Committee and the former president of the Korean Bioethics Society. She is a Chief of Editorial Board of Korea National Institute for Bioethics Policy. She is one of the organizers of the Korean Neuroethics Study Group established in 2017. She has broad interest in the ethical, legal and social implications of neuroscience. This includes the impact of neuroscientific research on human, neurogenetics, brain injury, adolescence brain science, and neurological evidence.

NEIL LEVY Dr. Neil Levy received his PhD in Continental Philosophy in 1995 and a second PhD, this time in analytic philosophy, in 2006. He was a Research Fellow at the Centre for Applied Philosophy and Public Ethics, University of Melbourne, from 2002 to 2009. In 2010 he moved to the Florey Institute of Neuroscience and Mental Health, where he was Head of Neuroethics and an ARC Future Fellow. From 2006 onwards, he has held appointments at the University of Oxford, where he is currently Leverhulme Visiting Professor. From 2016, he will be half time at Oxford and half time at Macquarie. Neil’s current research is focused on a number of questions concerning how the cognitive sciences can illuminate traditional philosophical debates. He is especially interested in the extent to which ascriptions of moral responsibility continue to be justified in the light of findings in neuroscience and social psychology on action control, and in how nonconscious representations affect action. He also works on free will and moral responsibility more broadly, on applied ethics and the philosophy of psychology.

27 DELEGATES

ANA MAIQUES Ana Maiques is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain; developing innovative technologies to monitor and stimulate the brain. She was nominated by IESE as one of the most influential entrepreneurs under 40 in Spain in 2010, she was the only woman on that list. She received the EU Prize for Women Innovators from the European Commission EC in 2014. Also in 2014, she was an award recipient of the International Women’s Entrepreneurial Challenge. In 2015 & 2016, she was named one of most inspiring women on the Inspiring Fifty list in Europe of women technological leaders and innovators. As a company, Neuroelectrics received the Best Start- up in Health Award in 2015 by Wired UK magazine and in 2016 was recognized as one of the “Best Entrepreneurial Companies in America” by Entrepreneur Magazine’s Entrepreneur 360™ List, the most comprehensive analysis of private companies in America. Ana continues to break the barriers for women and entrepreneurs bringing together science and technology in an impactful way. CHRIS MARTIN Chris Martin is the Interim Vice President for Science Programs at The Kavli Foundation, where he has been a Science Program Officer since 2013. He leads the Foundation’s interactions with its 20 endowed Kavli Institutes around the world in the fields of Theoretical Physics, Astrophysics, Nanoscience, and Neuroscience and builds catalytic opportunities to advance scientific research and funding, such as the U.S. BRAIN Initiative. Dr. Martin’s interests span the continuum from physics to public policy. Prior to joining the Foundation, he was a professor of physics and astronomy at Oberlin College (2004-2013) where he studied the Milky Way Galaxy using the Herschel Space Observatory, long duration balloon missions, and telescopes around the world. During his tenure at Oberlin, he spent a year as an American Association for the Advancement of Science Congressional Fellow with the United States Senate Committee on Commerce, Science, and Transportation and was involved in the America COMPETES Reauthorization Act of 2010, space policy, nanotechnology, and the federal funding of science research. Dr. Martin completed his Ph.D. in theoretical physics at the University of California Santa Barbara in 1999, and then became the Station Science Leader at the Amundsen-Scott South Pole Station and spent two years wintering over at the bottom of the Earth during his postdoctoral fellowship at the Harvard Smithsonian Center for Astrophysics.

HANNAH MASLEN Hannah Maslen is the Deputy Director of the Oxford Uehiro Centre for Practical Ethics. Hannah is a Research Fellow at New College and at the Oxford Martin School. She works on a wide range of topics in applied philosophy and ethics; from neuroethics, to moral emotions and criminal justice. She is a Principal Investigator on the Horizon 2020 BrainCom project, which aims to advance the basic understanding of speech networks in the cerebral cortex, and to develop rehabilitation solutions using innovative brain-computer interfaces. She leads the work package on ‘Ethics, Implants and Society’. You can find more information about her on her website (https://hannahmaslen.wordpress.com).

AGNES MCMAHON Agnes McMahon joined The Kavli Foundation in August 2018 as the inaugural Science Program Fellow. Prior to her work at the Foundation, she served as the Program Manager for the ENIGMA Consortium, an international collaboration in neuroimaging and genomics. Agnes began her career with a B.S. from the University of North Carolina and a post-baccalaureate fellowship in functional neuroimaging at the Duke- UNC Brain Imaging and Analysis Center. She then earned her M.S. in Clinical Science from the University of Colorado, culminating in a thesis on adolescent brain structure in substance use disorder. After graduate school, Agnes joined the Cognitive Neurology division at Johns Hopkins University to research non-verbal autism spectrum disorder. In Agnes’s current role with The Kavli Foundation, she provides coordination and support for the International Brain Initiative. She also contributes to the Foundation’s broader neuroscience efforts, including activities for the US BRAIN Initiative.

28 DELEGATES

KENTARO MORITA Kentaro Morita is a psychiatrist and researcher at the University of Tokyo in Tokyo, Japan. He obtained his medical degree in 2010 at Nippon Medical School and has completed his medical training at the University of Tokyo Hospital. He currently practices in adolescence and adult psychiatry giving care in both Japanese and English. Dr. Morita is also a researcher in the field of psychiatry with primary interest in mental illnesses such as Schizophrenia. His research is mainly based on neurobiological aspects of mental illness, such as neurophysiology and neuroimaging, with a future goal of applying these methods to early detection/intervention and rehabilitation. He is currently finishing his Ph.D., which is focused on eye movement abnormalities in schizophrenia and their significance in everyday life. He has been conducting this research under the supervision of Ryota Hashimoto at the National Center of Neurology and Psychiatry, Kenichiro Miura at the University of Kyoto, and Kiyoto Kasai at the University of Tokyo within the Brain/MINDS project. Dr. Morita is a member of the Japanese Society of Psychiatry and Neurology, the Japanese Society of Biological Psychiatry, the Japanese Society of General Hospital Psychiatry, the Japanese Society of Schizophrenia Research, the Japanese Neuroscience Society, and an International Member of the American Psychiatric Association.

EISUKE NAKAZAWA Eisuke Nakazawa, PhD, is a lecturer in the Department of Biomedical Ethics at the University of Tokyo Graduate School of Medicine (Japan). His research interests lie in neuroethics, research ethics and philosophy of science. His recent book publication is Ethics of Decoded Neurofeedback in Clinical Research, Treatment, and Moral Enhancement (Nakazawa E et al. 2016). American Journal of Bioethics Neuroscience 7(2): 110–117.

SHIGEO OKABE Shigeo Okabe is a professor of Cellular Neurobiology in the Graduate School of Medicine at the University of Tokyo. Shigeo is also the director of the Brain Medical Science Collaboration Division at RIKEN Centre for Brain Science. Shigeo obtained his M.D. at the University of Tokyo School of Medicine in 1986 and Ph.D. in the Division of Medical Science at The Graduate School of the University of Tokyo in 1993. His research interests include neuron and glia biology, synapse development and remodeling, postsynaptic density, synapse plasticity, neuronal cytoskeleton and neurodevelopment disorders.

HIDEYUKI OKANO Hideyuki Okano received his M.D. in 1983 and Ph.D. in 1988 from Keio University. He held a post- doctoral position at Johns Hopkins University School of Medicine. He was appointed full professors at Tsukuba University School of Medicine in 1994, Osaka University School of Medicine in 1997, and returned to Keio University Medical School in 2001 as a full professor of Physiology. Since 2007, he has been the Dean of Keio University Graduate School of Medicine, or Keio University School of Medicine. In 2009, his group developed a transgenic technology of common marmoset (Sasaki et al., Nature, 2009). He has been a Project Leader of Japan Brain/MINDS since 2014.

29 DELEGATES

LINDA RICHARDS Linda J. Richards, PhD, FAA, FAHMS is a Professor of Neuroscience and Deputy Director of the Queensland Brain Institute at The University of Queensland, Brisbane, Australia. She is a Fellow of both the Australian Academy of Science and the Australian Academy of Health and Medical Sciences and is a National Health and Medical Research Council Principal Research Fellow. She is President of the Australasian Neuroscience Society and co-chair of the Australian Brain Alliance. Professor Richards is head of the brain development and disorders laboratory at QBI. Her laboratory team strives to understand how the brain forms during development and how these processes are disrupted causing human developmental brain disorders and brain cancer. Professor Richards is a leading expert on the formation of the corpus callosum and is scientific advisor and patron for AusDoCC. In 2015 she co- founded an International Consortium for the Corpus Callosum and Cerebral Connectivity with colleagues from Australia, USA, France and Brazil. The consortium brings together clinicians and scientists working to identify the causes of developmental brain disorders and how best to provide support and care for affected individuals and their families. Professor Richards has received a number of awards and fellowships throughout her career including the Charles Judson Herrick Award from the American Association of Anatomists in 2004 and the Nina Kondelos award from the Australasian Neuroscience Society in 2010. Professor Richards is passionate about the public awareness of science and in 2006 she founded the Australian Brain Bee Challenge, a competition for high school students to learn about the brain. Over 30,000 high school students have participated in the challenge and students from Australia have won the international brain bee competition three times and placed in every event since 2006.

TONY PRESCOTT I am a Professor of Cognitive Robotics at the University of Sheffield and Director of Sheffield Robotics, an interdisciplinary research institute across both Universities in Sheffield. I am a researcher, educator, and technology developer working in the fields of synthetic psychology, computational neuroscience, and bio-inspired robotics. A particular focus is on the investigation of biomimetic and biohybrid systems: an example of the former would be an animal-like or humanoid robot, of the latter, a human- machine interface. My current research is directed towards (i) social cognition for humanoid robots (three EU projects in this area); (ii) active touch sensing for attention and orienting; (iii) assistive and field robotic technologies; (iv) haptic interfaces for sensory augmentation; and (v) societal and ethical issues in technology.

ERIC RACINE Dr. Eric Racine is a leading international researcher in bioethics with recognized contributions to the development of neuroethics and pragmatic ethics. He is the author of Pragmatic Neuroethics: Improving Treatment and Understanding of the Mind-Brain, published by MIT Press. Inspired by philosophical pragmatism, his research aims to bring to the forefront the lived experience of ethically problematic situations by patients and stakeholders and then to resolve them collaboratively through deliberative and evidence-informed processes. You can find more information about him at http:// www.pragmatichealthethics.ca/member/eric-racine-2/.

30 DELEGATES

JULIE ROBILLARD Julie Robillard is a recently appointed Assistant Professor of Neurology that leads a research program at the intersection of dementia, ethics, and technology. Her current research is aimed at evaluating the quality and ethics of online health information and computerized tools for dementia screening and diagnosis. Dr. Robillard holds a B.Sc. in Biology from the Université de Montréal and became interested in a career in research while working as an undergraduate research assistant in a neuropharmacology lab where she learned to record electrical signals from brain cells. She then moved to Vancouver to complete her PhD in neuroscience at UBC, focusing on the mechanisms underlying synaptic plasticity, a model for learning and memory, in the aging brain. During her PhD, Dr. Robillard became interested in how findings from neuroscience laboratories impact the lives of individuals and societies. To investigate this further, she joined the National Core for Neuroethics at UBC for postdoctoral training where she built on her thesis work in a way that emphasizes the human translational side of neuroscience. Now an Assistant Professor at UBC, Dr. Robillard’s goals are to ensure that older adults have access to high quality online information to support their health decision-making, and to ensure that new technological innovations for the screening, diagnosis, and treatment of dementia are aligned with social values and meet the highest ethical standards to maximize the benefit and minimize the harms to our older demographic. Dr. Robillard’s position in the UBC Division of Neurology at the UBC Department of Medicine has provided her with the opportunity to engage with various stakeholders in health care, including physicians, other researchers, residents, students, and members of the public. She feels that the UBC Department of Medicine, the National Core for Neuroethics, and Djavad Mowafaghian Centre for Brain Health, all together, provide a rich and productive research environment, ideal for her research. She has co-chaired the 2014 Brain Matters! Vancouver International conference, organized outreach programs showcasing the research done by students in the UBC Neuroscience graduate program, and has been to invited to present her work at prestigious conferences around the world. This summer, she will present her work on online self-assessments for dementia at the 2015 Alzheimer Congress in London, UK and at the Alzheimer Association International Conference in Washington, DC. Aside from research, she enjoys mountain biking and sailing.

YOUNG-JOON RYU Young-Joon is a professor in the Department of Pathology at the Kangwon National University Hospital and College of Medicine, and is the lead professor in the Department of Medical Humanities and Med- ical Ethics at Kangwon National University College of Medicine. He is a member of many professional organizations, including the National Bioethics Council, Korean Bioethics Association, Korean Society for Medical Ethics, and Neuroethics Study Group. Young-Joon received his Ph.D. in Medicine (Medical History and Ethics) at Seoul National University in 2011 and M.D. from Kosin University in 1998. He completed his residentship training in the Department of Pathology at Korea University Hospital and served as a clinical fellow at the Asan Medical Center from 2011-2013.

JEONG-WOO SOHN Dr. Jeong-woo Sohn is a professor in the department of medical science at Catholic Kwandong University in the Republic of Korea. He obtained his bachelor degree in nuclear engineering, master degree in cognitive science from Seoul Nation University in Korea and a Ph.D. degree in Brain and Cognitive Sciences from University of Rochester, NY, USA. Then he had been trained as a post-doctoral researcher in University of Pittsburgh, PA, USA. He returned to Korea and became a principal researcher at Medical Device Development Center of Daegu-Gyeonbuk Medical Innovation Foundation. He led a research group of medical imaging investigation during this time. His research interests are in brain and machine interface, motor learning and statistical analysis on neural data.

31 DELEGATES

SUNHAE SUL Sunhae is an Assistant Professor of Psychology and the director of Social Neuroscience Lab at Pusan National University. She graduated from Seoul National University with a M.A. in biological psychology and a Ph.D. in social psychology in 2010. Upon completing her post-doctoral training in neuroeconomics at the University of Zurich in Switzerland, she worked as a research professor and a post-doctoral researcher at Korea University and at Dartmouth College. Sunhae’s research centers around psychological and neural mechanisms underlying social decision making and moral judgment and the effect of prosocial (and anti-social) behaviors on well-being at both individual and societal levels. She is also interested in individual differences and cultural influences. GUOYU WANG Dr. Guoyu Wang studied at Fudan University, Free University of (Freie Universitat Berlin), University of Stuttgart (Universitat Stuttgart) and Dalian University of Technology. She is now a professor of ethics in the School of Philosophy at Fudan University, and serves as the Director of the Applied Ethics Research Center and Biomedical Ethics Research Center, Fudan University. Professor Wang has also assumed many other academic duties, including serving as vice-president of the Society for Science, Technology and Engineering Ethics, engaging in executive council of The Society of Technology Philosophy, Bioethics, Environmental Ethics and Chinese Society of Nanotoxicology. Professor Wang is mainly interested in the research field of Scientific and Technological Ethics. She is Chief Scientist of the Major Program of the National Social Science Fund of China, research on ethical, political, and regulatory framework of precision medicine. She has published several books and more than 60 papers in domestic and foreign journals. YI WANG I graduated from Beijing Normal University with a BS in biology in 2010. After college, I went to Univer- sity of Nebraska Medical Center (UNMC) for graduate study in pharmacology and experimental neu- roscience. I was awarded with a PhD degree in neuroscience in 2015. After that, I worked as a research associate in the Laboratory of Neuroimmunology and Regenerative Therapy, UNMC. At the same time, I studied biostatistics and epidemiology as a part-time student in the College of Public Health, UNMC and was awarded a master of public health degree in biostatistics in 2016. Now I am working as an assistant professor/researcher in Tongji University School of Medicine. My interests lie in studies on ethical standards of neuroscience projects in China and worldwide, and the neuroscience of ethics under the background of Chinese history. PAUL WOLPE Paul Root Wolpe, Ph.D. is the Asa Griggs Candler Professor of Bioethics, the Raymond F. Schinazi Distinguished Research Chair in Jewish Bioethics, a Professor in the Departments of Medicine, Pediatrics, Psychiatry, and Sociology, and the Director of the Center for Ethics at Emory University. Dr. Wolpe also serves as the first Senior Bioethicist for the National Aeronautics and Space Administration (NASA), where he is responsible for formulating policy on bioethical issues and safeguarding research subjects. He is Co-Editor of the American Journal of Bioethics (AJOB), the premier scholarly journal in bioethics, and Editor of AJOB Neuroscience, and sits on the editorial boards of over a dozen professional journals in medicine and ethics. Dr Wolpe is a past President of the American Society for Bioethics and Humanities; a Fellow of the College of Physicians of Philadelphia, the country’s oldest medical society; a Fellow of the Hastings Center, the oldest bioethics institute in America; and was the first National Bioethics Advisor to Planned Parenthood Federation of America. Dr. Wolpe moved to Emory University in the summer of 2008 from the University of Pennsylvania, where he was on the faculty for over 20 years in the Departments of Psychiatry, Sociology, and Medical Ethics. He was a Senior Fellow of Penn’s Center for Bioethics, and directed the Scattergood Program for the Applied Ethics of Behavioral Health and the Program in Psychiatry and Ethics at the School of Medicine. Dr. Wolpe is the author of over 125 articles, editorials, and book chapters in sociology, medicine, and bioethics, and has contributed to a variety of encyclopedias on bioethical issues. A futurist interested in social dynamics, Dr. Wolpe’s work focuses on the social, religious, ethical, and ideological impact of technology on the human condition. Considered one of the founders of the field of neuroethics, which examines the ethical implications of neuroscience, he also writes about other emerging technologies, such as genetic engineering, nanotechnology, prosthetics, and new reproductive technologies. 32 DELEGATES

JIE YIN Dr. Jie Yin is currently an associate professor at School of Philosophy, Fudan University. She is an interdisciplinary researcher working on bioethics, philosophy of medicine and Kant. She was trained in both medical school (Fudan University) and philosophy department (Fudan University, SUNY Albany). After graduating from SUNY Albany with her PhD in philosophy, she worked as a faculty in both department of philosophy and department of medical humanities at Southeast University (Nanjing, China), where she taught philosophy majors as well as medical students. She has won several teaching awards and was the principal investigator of a few research projects on bioethics, including a national- level grant on just health. Dr. Yin was awarded scholarship for attending international bioethics symposium by Kennedy Institute of Ethics (Georgetown University), and was invited by several research universities to give talks on bioethics, including Chinese University of Hong Kong, Hong Kong Baptist University, etc. She was the vice chair and associate professor at the department of philosophy (Southeast University) before she accepted the job offer at Fudan University. Dr. Yin has published articles and a book in Chinese on the themes of bioethics, analytic philosophy and Kant, and she also regularly teaches philosophy of nursing for nursing PhD students at eight top medical universities in China. She worked at two think tanks for Jiangsu Provincial Government and is now serving as consultant in several national-level interdisciplinary research projects regarding, broadly construed, science and technology related ethical issues. Dr. Yin is now working on a paper on philosophy of psychiatry while teaching a grad course on neuroethics and an undergrad course on Kant’s moral philosophy.

MARIELA ZIRLINGER Mariela Zirlinger has been an editor with Cell Press since 2011, first as a scientific editor and since 2017 as the Editor in Chief of Neuron. Neuron publishes interdisciplinary work in neuroscience, from molecular, to systems-level, including cognitive and theoretical domains. The journal commissions reviews and commentaries to highlight themes, synthesize insights and also serves as a platform to promote discussions at the interface of science and society. Mariela oversees the review process and the Neuron editorial team, and handles manuscript submissions across all areas of neuroscience. Her scientific training is in mouse genetics, behavior, and molecular and developmental neurobiology. Before joining Neuron, Mariela was a post-doc at Harvard. She completed her Ph.D. in Neurobiology at Caltech, after studying Chemistry at the University of Buenos Aires, Argentina.

33 NeQN Q5. In which “ contexts might a neuroscientific technology/innovation be used or deployed?” HELPFUL INFORMATION

CONRAD SEOUL HOTEL 10 Gukjegeumyung-ro (Yeouido) Yeongdeungpo-gu Seoul 07326, Korea Telephone: +82-2-6137-7000 Email: [email protected]

KOREAN TRANSLATION: Hotel: 콘래드서울 Address: 서울특별시 영등포구 국제금융로 10 (여의도동)

REIMBURSEMENT INSTRUCTIONS 1. Turn in all transportation receipts for GNS to [email protected] 2. For US delegates, fill out the W-9 Supplier Information Form 3. For international/non-US delegates, fill out the W-8 Form 4. Ensure all forms are signed and sent back to [email protected] 5. Reimbursements will take up to 30 days to process

Links to the W-9 and W-8 Forms can be found on the GNS website. If you have any questions, please email Emily Floyd (emilyfloyd@ emory.edu) or Celeste Fong ([email protected]).

If you require assistance regarding getting around, translation, etc. while you are in Seoul, you can contact: Stepheni Uh (GNS assistant/translator): +44-7898-793558 Heon Seok (KBRI): 010-7371-9926 Hyunjung Kim (KBRI): 010-9242-1167

35 WWW.GLOBALNEUROETHICSSUMMIT.COM